Reply to: “Inflammatory bowel disease epidemiology data from a prospective registry in Córdoba, Argentina: Raising the bar for future studies in Latin America”.

2021 ◽  
Author(s):  
Domingo Balderramo ◽  
María Rosa Defagó
Keyword(s):  
Inflammatory Bowel Disease ◽  
Latin America ◽  
Bowel Disease ◽  
Future Studies ◽  
Disease Epidemiology ◽  
Epidemiology Data ◽  
Inflammatory Bowel

scholarly journals Inflammatory Bowel Disease Epidemiology in São Paulo State, Brazil [Corrigendum]

2020 ◽  
Vol Volume 13 ◽  
pp. 221-222
Author(s):  
Rodrigo Galhardi Gasparini ◽  
Lígia Yukie Sassaki ◽  
Rogerio Saad-Hossne
Keyword(s):  
Inflammatory Bowel Disease ◽  
Bowel Disease ◽  
Sao Paulo ◽  
São Paulo ◽  
Disease Epidemiology ◽  
Paulo State ◽  
São Paulo State ◽  
Inflammatory Bowel

Mo1827 INCREASING FREQUENCY IN THE DIAGNOSIS AND DIFFERENTIAL CLINICAL PATTERNS OF INFLAMMATORY BOWEL DISEASE IN LATIN AMERICA AND THE CARIBBEAN: A MULTICENTER COHORT STUDY (EPILATAM)

2020 ◽  
Vol 158 (6) ◽  
pp. S-939
Author(s):  
Jesus K. Yamamoto-Furusho ◽  
Norma N. Parra-Holguin ◽  
Fabian Juliao ◽  
Guillermo R. Veitia ◽  
Esther A. Torres ◽  
...  
Keyword(s):  
Inflammatory Bowel Disease ◽  
Latin America ◽  
Cohort Study ◽  
Bowel Disease ◽  
Multicenter Cohort Study ◽  
Multicenter Cohort ◽  
Inflammatory Bowel ◽  
The Caribbean ◽  
Clinical Patterns

scholarly journals Study Insights into Gastrointestinal Cancer through the Gut Microbiota

2019 ◽  
Vol 2019 ◽  
pp. 1-8 ◽  
Author(s):  
Fanli Kong ◽  
Yi Cai
Keyword(s):  
Colorectal Cancer ◽  
Inflammatory Bowel Disease ◽  
Gut Microbiota ◽  
Bowel Disease ◽  
Gastrointestinal Diseases ◽  
Human Gut ◽  
Future Studies ◽  
Common Cancer ◽  
Inflammatory Bowel ◽  
Gi Cancers

The gut microbiome in human is recognized as a “microbial organ” for its roles and contributions in regulating the human homeostasis and metabolism. Gastrointestinal (GI) cancers, especially colorectal cancer (CRC), rank as the most common cancer-related deaths worldwide. Evidences have suggested that the disorder of gut microbiota, also named as “dysbiosis,” is related to the development of a variety of diseases such as inflammatory bowel disease (IBD) and the CRC. However, detailed mechanisms between disease and gut microbiota remain largely unknown. This review introduced the correlation between gastrointestinal diseases and the microbiota in human gut from the recent studies, as well as the roles of microbiota in manipulating the CRC and IBDs development, in order to facilitate future studies and to develop novel methods for the precaution, diagnosis, or even cure of gastrointestinal diseases. Additionally, we also elucidated the possibility of probiotics in treatment against CRC.

scholarly journals Inflammatory Bowel Disease in Latin America: A Systematic Review

2018 ◽  
Vol 17 ◽  
pp. 126-134 ◽  
Author(s):  
María Calderón ◽  
Nicole Minckas ◽  
Solange Nuñez ◽  
Agustín Ciapponi
Keyword(s):  
Systematic Review ◽  
Inflammatory Bowel Disease ◽  
Latin America ◽  
Bowel Disease ◽  
Inflammatory Bowel

scholarly journals P739 The progression of inflammatory bowel disease throughout Latin America: a systematic review

2019 ◽  
Vol 13 (Supplement_1) ◽  
pp. S490-S491
Author(s):  
P Kotze ◽  
F Underwood ◽  
A Damiao ◽  
J Ferraz ◽  
R Saad-Hossne ◽  
...  
Keyword(s):  
Systematic Review ◽  
Inflammatory Bowel Disease ◽  
Latin America ◽  
Bowel Disease ◽  
Inflammatory Bowel

scholarly journals P764 Phenotypic analysis of patients with inflammatory bowel disease: 23 year data of a centre in a South American country

2020 ◽  
Vol 14 (Supplement_1) ◽  
pp. S607-S607
Author(s):  
C C Páez Cancelado ◽  
R García Duperly ◽  
J Park ◽  
R López Panqueva ◽  
E E Londoño Schimmer ◽  
...  
Keyword(s):  
Inflammatory Bowel Disease ◽  
Latin America ◽  
Bowel Disease ◽  
University Hospital ◽  
Indeterminate Colitis ◽  
Second Line ◽  
Phenotypic Analysis ◽  
Surgical Interventions ◽  
Age Of Diagnosis ◽  
Inflammatory Bowel

Abstract Background Inflammatory Bowel Disease (IBD) includes Ulcerative Colitis (UC) and Crohn Disease (CD). In the last decade, there have been introduced therapeutic changes that have revolutionised the pharmacologic and surgical management of patients with IBD. The incidence of UC and CD has been increasing in Latin America but the exact prevalence is unknown. Our objective is to describe the demographic characteristics, clinical and therapeutic aspects of the IBD in patients that have presented in the University Hospital Fundación Santa Fe de Bogotá (UH-FSFB), Colombia. Methods Retrospective Descriptive Cohort Study. Clinical histories, pathology reports, and endoscopic results from data base HI-ISIS of the UH-FSFB and medical data between January 1996 and February 2019 were recollected, stored in Excel and analysed using IBM SPSS Statistics Visor. Patients with diagnosis of IBD were included. Patients with incomplete clinical histories were excluded. Results From 398 patients included in this study, 72.1% had UC, 25.6% CD and 2.3% Indeterminate Colitis. The average age of diagnosis was 43.54 years (range: 12–91). In both patients with UC and CD there were smaller proportions of men than women (0.9:1 for UC and 0.7:1 for CD). Of the patients with UC, 46.3% had been hospitalised. 37.2% presented with proctitis, 23.8% left colitis and 39% with pancolitis. 13.5% had an asymptomatic clinical disease, 22.4% mild, 15.3% moderate, and 48.8% severe. 12.9% received biological therapy (BT). 24.3% of patients received a second line BT. Fifteen per cent required surgical interventions (SI), of which there were no mortalities. 27% who were receiving BT required SI. Of the patients with CD, 82.4% required hospitalisation. 43.1% had an ileal, 9.8% colonic, 39.2% ileal- colonic, 0% isolated upper digestive and 21.6% perianal compromise. 34.3% had non-stenosing behaviour, 49% stenosing and 16.7% penetrating. 44.1% of patients with CD received BT of which 40% required a second line BT. 55.9% required SI, of which 1 mortality was reported. 71.1% who were receiving BT required a SI. Conclusion Our study contributes to the epidemiology and integral management required by patients with IBD in our environment. More studies are recommended that replicate our methodology in the population with IBD in both Colombia and Latin America.

scholarly journals Inflammatory bowel disease epidemiology in São Paulo State, Brazil

2018 ◽  
Vol Volume 11 ◽  
pp. 423-429 ◽  
Author(s):  
Rodrigo Galhardi Gasparini ◽  
Lígia Yukie Sassaki ◽  
Rogerio Saad-Hossne
Keyword(s):  
Inflammatory Bowel Disease ◽  
Bowel Disease ◽  
Disease Epidemiology ◽  
Paulo State ◽  
Inflammatory Bowel
Sign in / Sign up

Export Citation Format

Share Document